Developing an Ideal Risk Stratification Model for Metastatic Renal Cell Carcinoma

JAMA Oncol. 2023 Aug 1;9(8):1033-1035. doi: 10.1001/jamaoncol.2023.1764.

Authors

Georges Gebrael¹, Gliceida Galarza Fortuna¹, Neeraj Agarwal¹

Affiliation

¹ Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City.

PMID: 37347470
DOI: 10.1001/jamaoncol.2023.1764

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Renal Cell* / pathology
Humans
Kidney Neoplasms* / pathology
Prognosis
Retrospective Studies
Risk Assessment
Risk Factors